267 related articles for article (PubMed ID: 17277197)
1. Tamoxifen inhibits topoisomerases, depletes mitochondrial DNA, and triggers steatosis in mouse liver.
Larosche I; Lettéron P; Fromenty B; Vadrot N; Abbey-Toby A; Feldmann G; Pessayre D; Mansouri A
J Pharmacol Exp Ther; 2007 May; 321(2):526-35. PubMed ID: 17277197
[TBL] [Abstract][Full Text] [Related]
2. Tacrine inhibits topoisomerases and DNA synthesis to cause mitochondrial DNA depletion and apoptosis in mouse liver.
Mansouri A; Haouzi D; Descatoire V; Demeilliers C; Sutton A; Vadrot N; Fromenty B; Feldmann G; Pessayre D; Berson A
Hepatology; 2003 Sep; 38(3):715-25. PubMed ID: 12939598
[TBL] [Abstract][Full Text] [Related]
3. High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes.
Igoudjil A; Massart J; Begriche K; Descatoire V; Robin MA; Fromenty B
Toxicol In Vitro; 2008 Jun; 22(4):887-98. PubMed ID: 18299183
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
Geneve J; Hayat-Bonan B; Labbe G; Degott C; Letteron P; Freneaux E; Dinh TL; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1987 Sep; 242(3):1133-7. PubMed ID: 3116197
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice.
Lettéron P; Sutton A; Mansouri A; Fromenty B; Pessayre D
Hepatology; 2003 Jul; 38(1):133-40. PubMed ID: 12829995
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
Freneaux E; Fromenty B; Berson A; Labbe G; Degott C; Letteron P; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1990 Nov; 255(2):529-35. PubMed ID: 2123005
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions.
Deschamps D; DeBeco V; Fisch C; Fromenty B; Guillouzo A; Pessayre D
Hepatology; 1994 Apr; 19(4):948-61. PubMed ID: 8138270
[TBL] [Abstract][Full Text] [Related]
8. Prevention of free fatty acid-induced hepatic lipotoxicity by carnitine via reversal of mitochondrial dysfunction.
Jun DW; Cho WK; Jun JH; Kwon HJ; Jang KS; Kim HJ; Jeon HJ; Lee KN; Lee HL; Lee OY; Yoon BC; Choi HS; Hahm JS; Lee MH
Liver Int; 2011 Oct; 31(9):1315-24. PubMed ID: 22093454
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome.
Deschamps D; Fisch C; Fromenty B; Berson A; Degott C; Pessayre D
J Pharmacol Exp Ther; 1991 Nov; 259(2):894-904. PubMed ID: 1941634
[TBL] [Abstract][Full Text] [Related]
10. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices.
Vickers AE; Bentley P; Fisher RL
Toxicol In Vitro; 2006 Oct; 20(7):1173-82. PubMed ID: 16545538
[TBL] [Abstract][Full Text] [Related]
11. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in livers of mice after acute inhibition of beta-oxidation.
van der Leij FR; Bloks VW; Grefhorst A; Hoekstra J; Gerding A; Kooi K; Gerbens F; te Meerman G; Kuipers F
Genomics; 2007 Dec; 90(6):680-9. PubMed ID: 17933490
[TBL] [Abstract][Full Text] [Related]
13. The regulation of mitochondrial fatty acid oxidation and hepatic gene expression by catecholamine.
Barke RA; Brady PS; Brady LJ
J Surg Res; 1993 Feb; 54(2):95-101. PubMed ID: 8479178
[TBL] [Abstract][Full Text] [Related]
14. Prolonged ethanol administration depletes mitochondrial DNA in MnSOD-overexpressing transgenic mice, but not in their wild type littermates.
Larosche I; Choumar A; Fromenty B; Lettéron P; Abbey-Toby A; Van Remmen H; Epstein CJ; Richardson A; Feldmann G; Pessayre D; Mansouri A
Toxicol Appl Pharmacol; 2009 Feb; 234(3):326-38. PubMed ID: 19063909
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis.
Cole LK; Jacobs RL; Vance DE
Hepatology; 2010 Oct; 52(4):1258-65. PubMed ID: 20658461
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of the deleterious effects of tamoxifen on mitochondrial respiration rate and phosphorylation efficiency.
Cardoso CM; Custódio JB; Almeida LM; Moreno AJ
Toxicol Appl Pharmacol; 2001 Nov; 176(3):145-52. PubMed ID: 11714246
[TBL] [Abstract][Full Text] [Related]
17. Effect of stavudine on mitochondrial genome and fatty acid oxidation in lean and obese mice.
Gaou I; Malliti M; Guimont MC; Lettéron P; Demeilliers C; Peytavin G; Degott C; Pessayre D; Fromenty B
J Pharmacol Exp Ther; 2001 May; 297(2):516-23. PubMed ID: 11303038
[TBL] [Abstract][Full Text] [Related]
18. Hepatic toxicity of dronedarone in mice: role of mitochondrial β-oxidation.
Felser A; Stoller A; Morand R; Schnell D; Donzelli M; Terracciano L; Bouitbir J; Krähenbühl S
Toxicology; 2014 Sep; 323():1-9. PubMed ID: 24881592
[TBL] [Abstract][Full Text] [Related]
19. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice.
Tanaka N; Moriya K; Kiyosawa K; Koike K; Gonzalez FJ; Aoyama T
J Clin Invest; 2008 Feb; 118(2):683-94. PubMed ID: 18188449
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids.
Akkaoui M; Cohen I; Esnous C; Lenoir V; Sournac M; Girard J; Prip-Buus C
Biochem J; 2009 May; 420(3):429-38. PubMed ID: 19302064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
